FibrilNet maps conserved and tissue-specific molecular environments across systemic amyloidoses

Systemic amyloidoses are initiated by distinct amyloidogenic precursor proteins but frequently contain recurrent extracellular, complement, lipid-transport and matrix-remodelling components. Whether these recurrent proteins form a conserved systems-level environment across amyloid diseases, and how strongly that environment depends on precursor and tissue context, remains unresolved. We developed FibrilNet, a network framework that integrates experimentally defined amyloid proteomes with a human protein protein interaction graph and Gene Ontology derived semantic information. FibrilNet compares topology-only random walk with restart (RWR) with ontology aware semantic RWR in frozen leave-one-out module reconstruction and precursor-seeded prioritization tasks. The human graph contains 17,997 proteins and 925,977 physical interactions, with a 9-dimensional semantic representation of interaction context. In expanded cardiac transthyretin amyloidosis (ATTR), semantic-RWR increased mean reciprocal rank (MRR) from 0.00167 to 0.05015 and Recall@100 from 0.0199 to 0.3377, improving 132 of 151 held-out targets. Significant semantic gains were also observed in renal serum amyloid A amyloidosis (AA) and leukocyte chemotactic factor 2 amyloidosis (ALECT2). Across compact ATTR, light-chain amyloidosis (AL), AA and ALECT2 modules, APCS, VTN and TIMP3 formed a direct four-disease recurrent core, while APOE occurred in three of four modules. A tissue-aware ATTR analysis showed limited overlap between cardiac and neurologic modules (19 shared proteins; Jaccard 0.0569). In the hTTR-A97S peripheral-nerve model, semantic-RWR significantly improved reconstruction of the 202-protein mapped neurologic module, with the strongest evidence concentrated in the downregulated proteomic program. TTR-seeded propagation improved with semantic information but remained weak in absolute terms, separating precursor identity from the distributed downstream molecular environment. These results support a multilayer model in which a restricted conserved amyloid environment coexists with precursor-, tissue- and disease-specific organization